| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.152.125.326 $ | +335.899.951 $ | +206,0 % | 13 | 766.555.025 $ | +384.460.139 $ | +260,0 % | 8 | 306.367.000 $ | +74.152.100 $ | +33,3 % | 4 | ||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 194.500.000 $ | -44.450.000 $ | -18,6 % | 1 | 238.950.000 $ | +110.525.000 $ | +86,1 % | 1 | 128.425.000 $ | +65.882.000 $ | +105,3 % | 1 |
| Erasca, Inc. | ERAS | → 0 | Neutral | 180.407.000 $ | +132.047.000 $ | +273,1 % | 1 | 48.360.000 $ | +15.333.000 $ | +46,4 % | 1 | ||||
| IDEAYA Biosciences, Inc. | IDYA | → 0 | Neutral | 114.954.000 $ | -8.633.750 $ | -7,0 % | 1 | 123.587.750 $ | +50.120.750 $ | +68,2 % | 1 | 73.467.000 $ | +3.155.100 $ | +4,5 % | 1 |
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 91.824.150 $ | -18.703.350 $ | -16,9 % | 1 | 110.527.500 $ | +103.902.500 $ | +1.568,3 % | 1 | ||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 105.440.000 $ | +75.140.000 $ | +248,0 % | 1 | |||||||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 84.405.000 $ | +79.403.000 $ | +1.587,4 % | 1 | |||||||||
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 47.844.326 $ | -32.377.549 $ | -40,4 % | 1 | 80.221.875 $ | +48.806.989 $ | +155,4 % | 1 | ||||
| Abivax S.A. | ABVX | → 0 | Schwach | 75.161.250 $ | +21.219.250 $ | +39,3 % | 1 | 53.942.000 $ | +18.708.500 $ | +53,1 % | 1 | ||||
| Cidara Therapeutics, Inc. | → 0 | 68.475.900 $ | +32.565.900 $ | +90,7 % | 1 | ||||||||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 62.760.000 $ | +25.548.000 $ | +68,7 % | 1 | ||||||||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 57.671.250 $ | +38.609.250 $ | +202,5 % | 1 | ||||||||
| Akero Therapeutics, Inc. | → 0 | 56.976.000 $ | -7.056.000 $ | -11,0 % | 1 | ||||||||||
| ARVINAS, INC. | ARVN | → 0 | Neutral | 47.499.000 $ | +12.171.000 $ | +34,5 % | 1 | ||||||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 47.438.400 $ | +23.013.650 $ | +94,2 % | 1 | ||||||||
| Immunocore Holdings plc | IMCR | → 0 | Neutral | 45.225.000 $ | +15.721.500 $ | +53,3 % | 1 | ||||||||
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Schwach | 44.494.950 $ | +29.362.950 $ | +194,0 % | 1 | ||||||||
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Schwach | 42.490.000 $ | +4.497.500 $ | +11,8 % | 1 | ||||||||
| 1.152.125.326 $ | +335.899.951 $ | +206,0 % | 13 | 766.555.025 $ | +384.460.139 $ | +260,0 % | 8 | 306.367.000 $ | +74.152.100 $ | +33,3 % | 4 | ||||